Real World Data, Epidemiology & Study Design Track
The afternoons of the Congress will now split into 2 tracks to provide extra insights into the upstream functions defining DEI process for sponsors. Topics will include how to address gaps in data sources for underrepresented populations, how to identify disparities in disease prevalence, and how real-world data can be harnessed to define trial design. Incorporating demographic understanding throughout epidemiology and data science is crucial for scientific goal setting in diversity action plans required by the FDA.
Exclusive Pre-Day Workshops
May 5 will feature as an interactive pre-day workshop that furthers the internal and external alignment of sponsors to address DEI barriers in clinical studies. Receive more in-depth insights, case studies, and use cases of strategy deployment and how DEI measures translate to improved recruitment and retention. Hear how sponsors adapt their initiatives, learn from failures and identify best practices through presentations, panel discussions, and roundtable breakouts.
Startups Showcase
As the health equity industry expands and company partnerships multiply, the value in DEI solutions and businesses is under the scope for commercial potential. We are introducing an innovation showcase that enables emerging companies and vendors with the most unique services to receive exposure to our entire-ecosystem audience and catapult their business development needs.
Investor & Start-Ups Lunch
To match the exponential growth of health equity companies we are inviting investors to understand how to navigate the health equity and clinical trials industry at an exclusive lunch meet and greet. Network with VCs who have invested in health equity businesses and understand the commercial value of DEI services, explore the landscape of health equity and the factors propelling the rapid growth of this sector.